newsfilter
← Latest News
Business Wire·

ChromaDex to Present at Canaccord Genuity's 44th Annual Growth Conference

ChromaDex Corp. (NASDAQ:CDXC), the global authority on nicotinamide adenine dinucleotide (NAD+) research with a focus on healthy aging, today announced that its Chief Executive Officer, Rob Fried, and Interim Chief